CRISTINA ROSZEL: Open Payments
NPI 1770707689 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$938 in 47 payments from 18 companies in 2025. Trend: 2023 $1,017 · 2024 $804 · 2025 $938
Food & beverage: $938
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $187 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $155 |
| Novo Nordisk Inc | 6 | $114 |
| Exact Sciences Corporation | 5 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| Abbott Laboratories | 2 | $48 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| PFIZER INC. | 2 | $37 |
| Amgen Inc. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 1 | $30 |
Products named: JARDIANCE, XIFAXAN, The Cologuard Plus Collection Kit, Ozempic, MOUNJARO, FREESTYLE LIBRE 3, Auvelity, PREVNAR 20.
Industry payments across NY — which companies pay providers there.
